Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
read-across from similar mixture/product
Adequacy of study:
key study
Study period:
2000
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data

Data source

Reference
Reference Type:
review article or handbook
Title:
Amended Final Report on the Safety Assessment of Oryza Sativa (Rice) Bran Oil, Oryza Sativa (Rice) Germ Oil, Rice Bran Acid, Oryza Sativa (Rice) Bran Wax, Hydrogenated Rice Bran Wax, Oryza Sativa (Rice) Bran Extract, Oryza Sativa (Rice) Extract, Oryza Sat
Year:
2006
Bibliographic source:
International Journal of Toxicology - CIR database
Report date:
2006

Materials and methods

Principles of method if other than guideline:
Data are extracted from the 2006 review of the International Journal of Toxicology about the assessment of rice derivates. Since the study reported is dated back to 2000 (Cosmepar. 2000. Study of the innocuousness of a product by single oral administration. Unpublished data submitted by CTFA, June 20, 2002. 17 pages) we assume that it was performed according to OECD 401
GLP compliance:
not specified

Test material

Constituent 1
Reference substance name:
Hydrolyzed Rice Protein
IUPAC Name:
Hydrolyzed Rice Protein
Test material form:
liquid

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Doses:
2 g/kg
No. of animals per sex per dose:
5
Control animals:
not specified

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
other: No mortality or other clinical signs were reported.
Effect level:
> 2 000 mg/kg bw

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The substance is not toxic for ingestion according to criteria set out in Regulation (EC) n. 1272/2008 (CLP)